Five Prime Therapeutics brought me in as Creative Director for a full rebrand, website redesign, and marketing and PR materials. All of it running parallel to stage 3 clinical trials for a groundbreaking cancer treatment. The timeline was tight by any standard. For a biotech in the middle of a pivotal trial, it was extraordinary.Less than three months after the brand relaunch, with positive trial results in hand, Five Prime was acquired by Amgen for 1.9 billion dollars.